PMID: 6402811Mar 1, 1983Paper

Interaction of fibronectin with complement component C3

Scandinavian Journal of Immunology
A Hautanen, J Keski-Oja

Abstract

The activation of the complement component C3 generates C3a and C3b fragments, and the physiological cleavage of C3b further yields C3c and C3d fragments. We studied here by enzyme immunoassay the ability of human plasma fibronectin to interact with native C3 of human sera and with isolated C3c and C3d fragments of C3. C3 from sera of all six individuals tested bound to solid-phase fibronectin. Soluble fibronectin bound to solid-phase C3c and C3d, and fluid-phase C3c and C3d also bound to solid-phase fibronectin. The binding of fibronectin to solid-phase C3c and C3d could be inhibited by fluid-phase C3c and C3d. The results suggest the possibility that soluble fibronectin may attach to C3-coated particles or that C3-coated particles may adhere to fibronectin-containing structures.

References

Jan 1, 1979·Advances in Immunology·A N Theofilopoulos, F J Dixon
Oct 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·A VaheriR Timpl
Jul 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·S K Law, R P Levine
Jan 1, 1978·Advances in Immunology·T E Hugli, H J Müller-Eberhard
Apr 1, 1979·The Journal of Experimental Medicine·R D SchreiberH J Müller-Eberhard
Jan 1, 1979·Advances in Protein Chemistry·R R Porter, K B Reid
Dec 1, 1978·The Journal of Experimental Medicine·R D Schreiber, H J Müller-Eberhard
Dec 14, 1978·Nature·P Kuusela
Jul 15, 1977·International Journal of Cancer. Journal International Du Cancer·E Engvall, E Ruoslahti
Jan 1, 1980·Advances in Immunology·H J Müller-Eberhard, R D Schreiber
Jan 1, 1981·Immunological Communications·C HarrisB Anderson
Jul 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·D H BingR O Hynes
Nov 1, 1982·Immunology Letters·A HautanenI Seppälä
Feb 8, 1980·Molecular and Cellular Biochemistry·E PearlsteinA Garcia-Pardo
Jan 1, 1981·Collagen and Related Research·E RuoslahtiE G Hayman
Jun 1, 1981·Biochemical and Biophysical Research Communications·J Keski-OjaE Engvall

❮ Previous
Next ❯

Citations

Jan 1, 1987·Rheumatology International·V ToschiG F Fiorini
Jan 1, 1995·Archives of Dermatological Research·M Sztaba-Kania, W Placek
Jan 1, 1994·International Journal of Clinical & Laboratory Research·G SpiraM Paizi
Jan 1, 1984·Developmental and Comparative Immunology·E Johnson, P Smith
Mar 24, 2005·Journal of Cellular and Molecular Medicine·Mihaela GherghiceanuE Mandache
Oct 1, 1987·Annals of the Rheumatic Diseases·K E HerbertD L Scott
Jan 1, 1990·Rheumatology International·M W RobinsonD L Scott
Jun 1, 1991·Journal of the American Academy of Dermatology·N Domloge-HultschK B Yancey
Nov 1, 1986·Scandinavian Journal of Immunology·G Baatrup, S E Svehag
Feb 1, 1986·Scandinavian Journal of Immunology·J SorvilloE Pearlstein
Sep 1, 1984·The Journal of Pediatrics·M C YoderR A Polin
May 15, 2013·Seminars in Immunology·Jonathan D Leslie, Roberto Mayor
Feb 27, 2007·Biologicals : Journal of the International Association of Biological Standardization·Akiko Ishii-WatabeToru Kawanishi
Sep 1, 1984·The British Journal of Surgery·S J ChadwickH A Dudley
Sep 1, 1986·The British Journal of Surgery·S J ChadwickH A Dudley
Mar 1, 1988·European Journal of Immunology·F S RizviA Capron
Nov 1, 1985·European Journal of Immunology·M A OuaissiA Capron
Aug 1, 2018·Frontiers in Immunology·Dawn M KochanekMaciej M Markiewski
Feb 1, 1994·FEMS Immunology and Medical Microbiology·D TorreC Zeroli
Jan 1, 1985·Immunology Letters·K CsehS Benedek

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.